Detalhe da pesquisa
1.
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update.
Cytotherapy
; 10(6): 633-41, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18836918
2.
Functional characterization of podia formation in normal and malignant hematopoietic cells.
J Leukoc Biol
; 71(3): 425-32, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11867680
3.
STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia.
Leuk Res
; 24(4): 331-7, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10713330
4.
Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.
Leukemia
; 25(10): 1587-97, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21647156
5.
Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia.
Ann Hematol
; 83(5): 316-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15064861
6.
A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13-cis retinoic acid.
Br J Haematol
; 117(1): 249-51, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11918565